Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPE study in acromegaly
NL-OMON41731Recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of pasireotide LAR and pegvisomant in acromegaly (2 arms), sponsored by Erasmus MC. Started Jul 2015; status: recruiting.
02
Drugs
pasireotide LARpegvisomant
03
Conditions
acromegaly
Beyond the preview
Go deeper on NL-OMON41731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41731.